Bone Marrow TransplantationHematopoietic Stem Cell TransplantationBone Marrow CellsTransplantation, HomologousBone MarrowHematopoietic Stem CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationTransplantation ConditioningWhole-Body IrradiationTransplantation ChimeraHematologic NeoplasmsBone and BonesStem CellsHematopoiesisTissue DonorsPeripheral Blood Stem Cell TransplantationLeukemiaGraft SurvivalBusulfanHistocompatibility TestingHistocompatibilityLiver TransplantationTreatment OutcomeAnemia, AplasticMice, Inbred C57BLCell DifferentiationAntigens, CD34Colony-Forming Units AssayRecurrenceLeukemia, Myeloid, AcuteBone Marrow DiseasesCord Blood Stem Cell TransplantationTransplantation, IsogeneicCyclophosphamideCombined Modality TherapyTime FactorsHematopoietic Stem Cell MobilizationBone Marrow PurgingRetrospective StudiesRemission InductionImmunosuppressive AgentsMyelodysplastic SyndromesGraft vs Leukemia EffectRadiation ChimeraHepatic Veno-Occlusive DiseaseKidney TransplantationChimerismFlow CytometryMyeloablative AgonistsHematologic DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation ImmunologyMultiple MyelomaPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensCells, CulturedBone Marrow ExaminationSevere Combined ImmunodeficiencyCell LineageT-LymphocytesSurvival AnalysisLymphocyte TransfusionGraft RejectionGranulocyte Colony-Stimulating FactorLeukemia, MyeloidCell TransplantationLymphocyte DepletionMesenchymal Stem Cell TransplantationSurvival RateAcute DiseaseGraft vs Tumor EffectBone RemodelingMelphalanImmunosuppressionBone Marrow NeoplasmsDisease-Free SurvivalLymphoma, Non-HodgkinCell SeparationAntineoplastic Combined Chemotherapy ProtocolsCytomegalovirus InfectionsFollow-Up StudiesHeart TransplantationSiblingsAntilymphocyte SerumSpleenVidarabineGranulocytesFetal BloodCytarabineUnrelated DonorsChimeraSalvage TherapyOrgan TransplantationLung TransplantationPancytopeniaStem Cell NicheMice, Inbred BALB CMice, Knockout